Fygg

Fygg is a science-led healthcare and biotechnology company focused on the oral mycobiome and its critical role in the fungal-gut-brain axis. Founded by Dr. Mahmoud Ghannoum, the scientist who coined the term "mycobiome," the company develops oral care solutions designed to balance the complex fungal and bacterial ecosystems in the mouth. Fygg leverages proprietary research to address systemic health issues through targeted oral hygiene, bridging the gap between dental care and overall wellness. Their product portfolio includes advanced hydroxyapatite-based toothpastes and oral health supplements formulated to optimize the oral environment. By targeting the mycobiome, Fygg aims to mitigate systemic inflammation and support the body's internal health axes.